Search
for

    Glossary Myasthenia Gravis

    autoimmune disorder causing muscle weakness and rapid fatigue

    Myasthenia Gravis (MG) is an autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. It occurs when the immune system produces antibodies that block or destroy many of the muscle receptor sites for acetylcholine, a neurotransmitter essential for muscle contraction. This disruption impairs communication between nerves and muscles, leading to symptoms such as drooping eyelids, double vision, and difficulty swallowing or breathing.

    Related Terms

    Research 10 of 200

    1. Generalized hair follicle hamartoma associated with alopecia and myasthenia gravis: report of a second case* Clinical and Experimental Dermatology · 1981 · 64 citations
    2. Generalized trichoepitheliomas with alopecia and myasthenia gravis: Clinicopathologic and immunohistochemical study and comparison with classic and desmoplastic trichoepithelioma Journal of the American Academy of Dermatology · 1986 · 54 citations
    3. No mucosal involvement in a patient with paraneoplastic pemphigus associated with thymoma and myasthenia gravis British Journal of Dermatology · 2008 · 29 citations
    4. Alopecia Areata Associated with Myasthenia Gravis and Thymoma: A Case of Alopecia with Marked Improvement Following Thymectomy and High Level Prednisolone Administration The Journal of Dermatology · 1997 · 21 citations
    5. Myasthenia Gravis Coexisting With Primary Sjögren's Syndrome: Report of Three Cases and Literature Review Frontiers in Neurology · 2020 · 6 citations
    6. Taste disorders and alopecia in myasthenia gravis BMC Neurology · 2024 · 5 citations
    7. Alopecia areata and myasthenia gravis presenting as paraneoplastic phenomena of breast cancer JAAD Case Reports · 2022 · 3 citations
    8. Twenty‐nail dystrophy and alopecia areata in an adult male with thymoma‐associated myasthenia gravis: A case report Clinical and Experimental Neuroimmunology · 2023 · 2 citations
    9. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis Clinical Cosmetic and Investigational Dermatology · 2026
    10. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis SHILAP Revista de lepidopterología · 2026
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →